|
1. |
Cancer of the pancreas |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 1-8
John T. Kalberer,
Preview
|
PDF (364KB)
|
|
摘要:
AbstractThe National Cancer Institute sponsored a one‐day workshop to discuss future plans for the study of pancreatic cancer. Ten participants discussed the limitations in progress against cancer of the pancreas and recommended studies in the areas of fundamental research, diagnosis, and treatment. They emphasized the need for coordination of clinical studies across the country, development of an early detection method, and participation of more biochemists to better define pancreatic pathophysiolog
ISSN:0022-4790
DOI:10.1002/jso.2930060102
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
2. |
Current therapy approaches of the division of cancer treatment with emphasis on pancreatic carcinoma |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 9-17
Stephen K. Carter,
Preview
|
PDF (404KB)
|
|
摘要:
AbstractThis paper outlines the background of the National Cancer Institute clinical drug testing program and introduces current concepts for integrating this program into disease‐oriented combined modality approaches to the primary treatment of cancer. The combined modality thrust involves chemotherapy, surgery, and/or radiotherapy and is illustrated by treatment protocols for adenocarcinoma of the pancreas developed by the Gastrointestinal Tumor Study Group organized by the NCI Division of Cancer Treatment. One study seeks a controlled evaluation of postoperative treatment with 5‐Fluorouracil and supervoltage radiation for improving disease‐free interval and survival in ductal, acinar, and undifferentiated variety of pancreatic adenocarcinoma. The other study compares the effectiveness of high‐dose radiation alone or with 5‐FU and medium‐dose radiation plus 5‐FU in localized but unresectable disease. A number of other combined modality approaches planned or in progress within the National Cancer Institute are brie
ISSN:0022-4790
DOI:10.1002/jso.2930060103
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
3. |
Hemoglobin II immunogenic properties of stroma vs. stroma‐free hemoglobin solution |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 19-28
Alan Cochin,
Tapas K. Das Gupta,
Richard Dewoskin,
Gerald S. Moss,
Preview
|
PDF (1002KB)
|
|
摘要:
AbstractIn recent years there has been considerable interest in the use of hemoglobin solution as a volume expander. This solution would be able to both pick‐up and off‐load oxygen as well as expand the circulating value. It is extremely important to know whether or not hemoglobin itself as well as stroma is antigenic, since an affirmative answer would preclude its use as a plasma expander.To obtain this answer, the following study was carried out. A group of white rabbits were challenged over a 21‐day period with either saline solution, hemolysates containing various concentrations of stroma, or stroma‐free hemoglobin solution. We found that stroma produced marked increase in gamma to globulin concentrations, phospholipid concentrations, and clotting times. In addition, marked thrombocytopenia was also noted. In contrast we found no such changes in animals given either saline solution or stroma‐free hemoglobin solution. The data indicate that the stroma is antigenic but that hemoglobin solution without stro
ISSN:0022-4790
DOI:10.1002/jso.2930060104
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
4. |
Studies on the effects of adenosine upon tumor growth in mice |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 29-38
Leonell C. Strong,
Debra Ishmael,
Preview
|
PDF (346KB)
|
|
摘要:
AbstractGrowth rates of spontaneous tumors of C3H and C3HB inbred mice were averaged together. Four series of tests using adenoisine as an inhibitor of tumor growth were used in a 0.05 molar concentration. The four series used were, (a) adenosine I, (b) adenosine II both for intraperitoneal injections, used singly and then combined for comparative analysis, (c) adenosine III, and (d) adenosine IV, both used for subcutaneous injections, of which series III was used in distilled water and series IV in physiological salt solution. Observations on tumor size were plotted at five time‐period intervals in order to determine growth rates. It was found that adenosine IV, in physiological salt solution, gave the greatest deviation from from the controls both in inhibiting tumor growth and also in stimulating tumor growth in mice of the different age and generation classes as determined in a lineal descent from a mouse which had received a liver‐emulsion injection. The subcutaneous injections of adenosine III gave only an early inhibition of tumors whereas the intraperitoneal injections of adenosine I and II brought about a constant inhibition of tumor growth during the life span of tumor‐bearing mice. Variations in the effect of adenosine upon tumor growth were found to be dependent upon 1. the age of the mouse and 2. the generation of descent removed from the original liver treatment (Strong, 1969a). These tests for tumor growth, therefore, provided a close examination of some of the variables involved in the use of adenosine as an inhibitor and as a stimulator of spontaneous tumor growth rates in
ISSN:0022-4790
DOI:10.1002/jso.2930060105
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
5. |
Extracorporeal chemotherapy with L‐asparaginase in man |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 39-48
Derek Sampson,
Tin Han,
Lee S. Hersh,
Gerald P. Murphy,
Preview
|
PDF (764KB)
|
|
摘要:
AbstractAn extracorporeal chemotherapy unit has been used in baboons and man. Blood was perfused over plates coated with L‐asparaginase in 4 hour perfusion studies. It was possible to lower serum asparagine levels almost to zero, and to render both human and animal lymphocytes unreactive to mitogenic stimulation. The toxicity associated with L‐asparaginase was avoided and the potential application of this technique to the treatment of human lymphatic leukemia is discus
ISSN:0022-4790
DOI:10.1002/jso.2930060106
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
6. |
Complete regression of metastatic tumors of the adult with antimitotic treatment |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 49-59
E. Pommatau,
M. Brunat,
H. Mayer,
M. Dargent,
Preview
|
PDF (1089KB)
|
|
摘要:
AbstractWe have presented 7 patients in whom metastatic carcinoma regressed by chemotherapy alone. They are well without evidence of disease for 5 to 10 years. The patients include 4 embryonal carcinoma of the testis, 1 uterine chorioepithelioma, 1 prostatic sarcoma, and 1 trabeculo‐follicular epithelioma of the thyroid. They received 1 or more courses of chemotherapy (trenimon or nitromin alone, or triple association actinomycin D, methotrexate, and cytoxan). We cannot explain why these are apparently cured and why others, treated with the same drugs, had no regression at all. No immunological studies were don
ISSN:0022-4790
DOI:10.1002/jso.2930060107
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
7. |
Scalene node excision biopsy in advanced prostate carcinoma |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 61-65
Fabian A. Sy,
Erol O. Gursel,
Ralph J. Veenema,
Joseph Buda,
Preview
|
PDF (257KB)
|
|
摘要:
AbstractIn 12 patients with disseminated prostate carcinoma, supraclavicular lymph node biopsy was performed. In 3 patients with palpable supraclavicular node, tumor cells were found in the lymph nodes. In the remaining 9 in whom there were no palpable nodes, unilateral left scalene lymph node excision biopsy revealed no evidence of tumor cells in the nodes in spite of diffuse bone metastasis. These findings suggest that unilateral scalene node biopsy did not provide additional information and has no advantage over the known parameters in staging of prostatic cancer.
ISSN:0022-4790
DOI:10.1002/jso.2930060108
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
8. |
Treatment of metastatic carcinoma of the prostate to bone with parathormone and radioactive phosphorous |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 67-72
Claude Merrin,
Suraj Bakshi,
Preview
|
PDF (240KB)
|
|
摘要:
AbstractEight patients with metastases to bone from carcinoma of the prostate were treated with a combination of parathyroid hormone and radioactive phosphorous. Seven of 8 patients reported substantial pain relief ranging from 1 to 8 months in duration. Several chemical parameters were altered during the priming period with parathyroid hormone but no objective response to the combination therapy was observed.
ISSN:0022-4790
DOI:10.1002/jso.2930060109
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
9. |
Anticancer therapy with Hydrea: Comparative study of daily vs, intermittent oral dosage |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 73-78
Irving M. Ariel,
Preview
|
PDF (272KB)
|
|
摘要:
AbstractNo significant difference can be demonstrated in this evaluation between daily doses and intermittent doses of Hydrea in either subjective or objective response. Although a slightly better result was obtained by the daily dose in patients with malignant melanoma, colonrectum carcinoma, sarcoma, and ovarian cancer. No significant increase in longevity was noted by the intermittent dose over the daily dose. Because the difference between the two methods of administration is so slight, the intermittent method recommends itself because of the superior hematopoietic picture that can be maintained following its implementation.
ISSN:0022-4790
DOI:10.1002/jso.2930060110
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
10. |
Timing of pedicle flap delays by measurements of flap oxygen and carbon dioxide |
|
Journal of Surgical Oncology,
Volume 6,
Issue 1,
1974,
Page 79-85
Jorge H. Reisin,
Randolph H. Guthrie,
Dicran Goulian,
Preview
|
PDF (461KB)
|
|
摘要:
AbstractOxygen and carbon dioxide partial pressures in canine pedicle flaps are measured with a mass spectrometer before and for a week following flap manufacture. These partial pressures are a direct reflection of a flap's blood supply. The initial insult to cutaneous blood circulation and its subsequent recovery are clearly documented.
ISSN:0022-4790
DOI:10.1002/jso.2930060111
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1974
数据来源: WILEY
|
|